Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 19988-19989 [2015-08521]

Download as PDF 19988 Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices asabaliauskas on DSK5VPTVN1PROD with NOTICES 3. Report title: Recordkeeping and Disclosure Provisions associated with Stress Testing Guidance. Agency form number: FR 4202. OMB control number: 7100–0348. Frequency: On-occasion. Reporters: State member banks, bank holding companies, and all other institutions for which the Federal Reserve is the primary federal supervisor. Estimated annual reporting hours: Recordkeeping, 18,000 hours; Disclosure, 8,000 hours. Estimated average hours per response: Recordkeeping, 180 hours; Disclosure, 80 hours. Number of respondents: Recordkeeping, 100; Disclosure, 100. General description of report: This information collection is voluntary and is authorized pursuant to sections 11(a), 11(i), 25, and 25A of the Federal Reserve Act (12 U.S.C. 248(a), 248(i), 602, and 611), section 5 of the Bank Holding Company Act (12 U.S.C. 1844), and section 7(c) of the International Banking Act (12 U.S.C. 3105(c)). To the extent the Federal Reserve collects information during an examination of a banking organization, confidential treatment may be afforded to the records under exemptions 4 and 8 of the Freedom of Information Act (FOIA) (5 U.S.C. 552(b)(4) and (8)). Abstract: The interagency guidance outlines high-level principles for stress testing practices, applicable to all Federal Reserve-supervised, FDICsupervised, and OCC-supervised banking organizations 1 with more than $10 billion in total consolidated assets. In developing a stress testing framework and in carrying out stress tests, banking organizations 2 should understand and clearly document all assumptions, uncertainties, and limitations, and provide that information to users of the stress testing results. To ensure proper governance over the stress testing framework, banking organizations should develop and maintain written policies and procedures. 1 The agencies that were party to the rulemaking were the Office of the Comptroller of the Currency (OCC); Board of Governors of the Federal Reserve System (Board); and Federal Deposit Insurance Corporation (FDIC). 2 For purposes of this guidance, the term ‘‘banking organization’’ means national banks and Federal branches and agencies supervised by the OCC; state member banks, bank holding companies, and all other institutions for which the Federal Reserve is the primary federal supervisor; and state nonmember insured banks and other institutions supervised by the FDIC. VerDate Sep<11>2014 17:42 Apr 13, 2015 Jkt 235001 Board of Governors of the Federal Reserve System, April 8, 2015. Robert deV. Frierson, Secretary of the Board. [FR Doc. 2015–08406 Filed 4–13–15; 8:45 am] BILLING CODE 6210–01–P FEDERAL RETIREMENT THRIFT INVESTMENT BOARD Sunshine Act; Notice of Meeting Parts open to the public begin at 8:30 a.m. April 20, 2015. PLACE: 10th Floor Board Meeting Room, 77 K Street NE., Washington, DC 20002. STATUS: Parts will be open to the public and parts closed to the public. MATTERS TO BE CONSIDERED: TIME AND DATE: Parts Open to the Public 1. Approval of the Minutes of the March 23, 2015 Board Member Meeting. 2. ED Comments 3. Monthly Reports a. Monthly Participant Activity Report b. Legislative Report 4. Quarterly Metrics Report a. Investment Policy b. Vendor Financials c. Audit Status d. Budget Review e. Project Activity Report 5. Annual Financial Audit—CLA 6. Mainframe Audit 7. DOL Presentation Part Closed to the Public 8. Security CONTACT PERSON FOR MORE INFORMATION: Kimberly Weaver, Director, Office of External Affairs, (202) 942–1640. Dated: April 10, 2015. Megan Grumbine, Deputy General Counsel, Federal Retirement Thrift Investment Board. [FR Doc. 2015–08675 Filed 4–10–15; 4:15 pm] BILLING CODE 6760–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcements PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 (FOA) GH15–002, Conducting Public Health Research in Georgia; FOA GH15– 003, Conducting Public Health Research Activities in Uzbekistan; FOA GH15– 006, Institutional Research Collaboration between the Liverpool School of Tropical Medicine and the Centers for Disease Control and Prevention; FOA GH15–007, Emerging Infectious Disease Detection in the Veterinary Public Health Sector in India; and FOA GH15–008, Conducting Operational Research to Identify Numbers and Rates, Determine Needs, and Integrate Services to Mitigate Morbidity and Mortality Among Internally Displaced Persons Affected by Emergencies. TIME AND DATE: 8:30 a.m.–1:30 p.m., EDT, May 6, 2015 (Closed) PLACE: Teleconference The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. STATUS: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Conducting Public Health Research in Georgia, FOA GH15–002; Conducting Public Health Research Activities in Uzbekistan, FOA GH15–003; Institutional Research Collaboration between the Liverpool School of Tropical Medicine and the Centers for Disease Control and Prevention, FOA GH15–006; Emerging Infectious Disease Detection in the Veterinary Public Health Sector in India, FOA GH15–007; and Conducting Operational Research to Identify Numbers and Rates, Determine Needs, and Integrate Services to Mitigate Morbidity and Mortality Among Internally Displaced Persons Affected by Emergencies, FOA GH15– 008.’’ MATTERS FOR DISCUSSION: CONTACT PERSON FOR MORE INFORMATION: Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road NE., Mailstop D–69, Atlanta, Georgia 30033, Telephone: (404) 639–4796. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\14APN1.SGM 14APN1 Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–08521 Filed 4–13–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Prevention and the Agency for Toxic Substances and Disease Registry. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting for the aforementioned committee: Time and Date: 2:00 p.m.–3:00 p.m., EST, May 11, 2015. Place: This meeting will be accessible by teleconference. Toll-free +1 (888) 790–1864, Participant Code: 5920580. Status: Open to the public limited only by the availability of telephone ports. Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters for Discussion: The agenda will include a follow up discussion on the Draft Guideline for the Prevention of Surgical Site Infections. Call materials will be made available to the public no later than 2 business days before the call. If CDC is unable to post the background material on the HICPAC site prior to the meeting, the background material will be posted on HICPAC’s Web site after the meeting. Background material is available at https:// www.cdc.gov/hicpac. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE., Mailstop A–31, Atlanta, Georgia 30333; Email: HICPAC@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and [FR Doc. 2015–08518 Filed 4–13–15; 8:45 am] BILLING CODE 4163–18–P Board of Scientific Counselors, Office of Infectious Diseases, BSC, OID asabaliauskas on DSK5VPTVN1PROD with NOTICES Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 8:00 a.m.–5:00 p.m., EDT, May 6, 2015. Place: CDC, Global Communications Center, 1600 Clifton Road NE., Building 19, Auditorium B3, Atlanta, Georgia 30333. Status: The meeting is open to the public, limited only by the space available. Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: Strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters for Discussion: The meeting will include a report from the Food Safety Modernization Act Surveillance Working Group of the BSC, OID; brief updates on priority issues for CDC’s infectious disease programs; and updates and discussions on CDC’s Surveillance Strategy and the Global Health Security Agenda. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639– 4461. The Director, Management Analysis and Services Office has been delegated Centers for Disease Control and Prevention VerDate Sep<11>2014 17:42 Apr 13, 2015 Jkt 235001 19989 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Initial Review The meeting announced below concerns Comparison and Validation of Screening Tools for Substance Use Among Pregnant Women, DP15–003, initial review. SUMMARY: This document corrects a notice that was published in the Federal Register on March 12, 2015 Volume 80, Number 48, page 13011. The times and dates should read as follows: Times and Dates: 9:00 a.m.–6:00 p.m., April 7–8, 2015 (Closed). M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F46, Atlanta, Georgia 30341, Telephone: (770)488–3585, EEO6@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. FOR FURTHER INFORMATION CONTACT: Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–08519 Filed 4–13–15; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) E:\FR\FM\14APN1.SGM 14APN1

Agencies

[Federal Register Volume 80, Number 71 (Tuesday, April 14, 2015)]
[Notices]
[Pages 19988-19989]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-08521]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcements (FOA) 
GH15-002, Conducting Public Health Research in Georgia; FOA GH15-003, 
Conducting Public Health Research Activities in Uzbekistan; FOA GH15-
006, Institutional Research Collaboration between the Liverpool School 
of Tropical Medicine and the Centers for Disease Control and 
Prevention; FOA GH15-007, Emerging Infectious Disease Detection in the 
Veterinary Public Health Sector in India; and FOA GH15-008, Conducting 
Operational Research to Identify Numbers and Rates, Determine Needs, 
and Integrate Services to Mitigate Morbidity and Mortality Among 
Internally Displaced Persons Affected by Emergencies.

Time and Date: 
8:30 a.m.-1:30 p.m., EDT, May 6, 2015 (Closed)

Place: Teleconference

Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.

Matters For Discussion: The meeting will include the initial review, 
discussion, and evaluation of applications received in response to 
``Conducting Public Health Research in Georgia, FOA GH15-002; 
Conducting Public Health Research Activities in Uzbekistan, FOA GH15-
003; Institutional Research Collaboration between the Liverpool School 
of Tropical Medicine and the Centers for Disease Control and 
Prevention, FOA GH15-006; Emerging Infectious Disease Detection in the 
Veterinary Public Health Sector in India, FOA GH15-007; and Conducting 
Operational Research to Identify Numbers and Rates, Determine Needs, 
and Integrate Services to Mitigate Morbidity and Mortality Among 
Internally Displaced Persons Affected by Emergencies, FOA GH15-008.''

Contact Person For More Information: Hylan Shoob, Scientific Review 
Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 
Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: 
(404) 639-4796.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and

[[Page 19989]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-08521 Filed 4-13-15; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.